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Background:  We performed the study to examine the impact of hemoglobin A1c (HbA1c) criterion on the screening of in-
creased risk for diabetes among health check-up subjects in Korea.
Methods:  We retrospectively analyzed clinical and laboratory data of 37,754 Korean adults (age, 20 to 89 years; 41% women) 
which were measured during regular health check-ups. After excluding subjects with previously diagnosed diabetes mellitus 
(n=1,812) and with overt anemia (n=318), 35,624 subjects (21,201 men and 14,423 women) were included in the analysis. 
Results:  Among the 35,624 subjects, 11,316 (31.8%) subjects were categorized as increased risk for diabetes (IRD) by fasting 
plasma glucose (FPG) criteria, 6,531 (18.1%) subjects by HbA1c criteria, and 13,556 (38.1%) subjects by combined criteria. There-
fore, although HbA1c criteria alone identifies 42% [(11,316−6,531)/11,316] fewer subjects with IRD than does FPG criteria, about 
20% [(13,556-11,316)/11,316] more subjects could be detected by including new HbA1c criteria in addition to FPG criteria. 
Among the 13,556 subjects with IRD, 7,025 (51.8%) met FPG criteria only, 2,240 (16.5%) met HbA1c criteria only, and 4,291 
(31.7%) met both criteria. Among subjects with impaired fasting glucose, 65% were normal, 32% were IRD, and 3% were diabe-
tes by HbA1c criterion. In receiver operating characteristic curve analysis, cutoff point of HbA1c with optimal sensitivity and 
specificity for identifying IRD was 5.4%.
Conclusion:  Although HbA1c criteria alone identifies fewer subjects with IRD than does FPG criteria, about 20% more could 
be detected by addition of HbA1c criteria. Further studies are needed to define optimal cutoff point of HbA1c and to establish 
screening and management guidelines for IRD.
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INTRODUCTION
The high economical burden and healthy implications of dia-
betes has led to increasing attempts to prevent its development. 
Interventions for subjects with ‘pre-diabetes’ or ‘increased risk 
for diabetes’ have been major focus for these prevention efforts. 
Therefore, identification of these subjects should be effective 
and reasonable.
  When American Diabetes Association (ADA) included the 
use of hemoglobin A1c (HbA1c) to diagnose diabetes mellitus 
with a cut point of ≥6.5% [1] and included this criteria in 2010 
guidelines, the ADA also stressed the continuum of risk for di-
abetes with all glycemic measures and did not formally identi-
fy an equivalent intermediate category for HbA1c. The group 
did note that those with HbA1c levels above the laboratory 
‘normal’ range but below the diagnostic cut point for diabetes 
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(5.7% to 6.4%) are at ‘increased risk for diabetes’ [1]. 
  However, epidemiological studies [2,3] have shown signifi-
cant discordance between HbA1c and glucose-based tests for 
defining high risk for diabetes. Moreover, the degree of diag-
nostic agreement of HbA1c criteria with the fasting glucose-
based criteria may be different across ethnic groups and popu-
lations [4-6]. 
  The aim of this study was to examine the differences in 
prevalence of using fasting plasma glucose (FPG) criteria and 
HbA1c criteria in defining the increased risk for diabetes (IRD) 
in Korean asymptomatic health check-up recipients. In addi-
tion, we analyzed the concordance between FPG criteria and 
HbA1c criteria and the sensitivities and specificities of many 
HbA1c cutoff points. 
METHODS
Subjects
We retrospectively analyzed clinical and laboratory data of 
37,754 Korean adults (age, 20 to 89 years; 41% women) which 
were recorded during regular health check-ups. After exclud-
ing subjects with previously diagnosed diabetes mellitus 
(n=1,812) and with overt anemia (hemoglobin concentration 
<12 g/dL) (n=318), 35,624 subjects (21,201 men and 14,423 
women) were categorized. IRD was defined by FPG (5.6 to 6.9 
mmol/L), HbA1c (5.7% to 6.4%), and combined criteria (FPG, 
5.6 to 6.9 mmol/L or HbA1c, 5.7% to 6.4%).
Measurements
Height and weight were measured with subjects wearing light 
clothing without shoes. Blood pressure was measured with an 
electric sphygmomanometer on the right arm with subjects in 
a sitting position after a 5-minute rest. Body mass index (BMI) 
was calculated as weight in kilograms divided by the square of 
the height in meters. Blood samples were obtained in the morn-
ing after an overnight fast. Plasma glucose was measured by 
the hexokinase method using an autoanalyzer (Toshiba, Tokyo, 
Japan). Standard liver function testing, total cholesterol, high 
density lipoprotein cholesterol, and triglycerides were also 
measured using an autoanalyzer (Toshiba). HbA1c was mea-
sured with ion-exchange high-performance liquid chromatog-
raphy using an automated analyzer (Variant II
TM; Bio-Rad Lab-
oratories, Hercules, CA, USA). Serum insulin concentrations 
were obtained employing an immunoradiometric assay (TFB, 
Tokyo, Japan). 
Statistics
Data are expressed as means±standard deviation. χ
2 tests were 
used to compare groups. Receiver operating characteristic 
(ROC) curves for HbA1c were plotted. Statistical analyses were 
performed using the SPSS version 14.0 for Windows software 
package (SPSS Inc., Chicago, IL, USA). P values less than 0.05 
were considered statistically significant.
RESULTS
The clinical characteristics of the study subjects are shown in 
Table 1. Among the 35,624 subjects without known diabetes, 
11,316 (31.8%) subjects were IRD by FPG criteria, 6,531 
(18.1%) by HbA1c criteria, and 13,556 (38.1%) by combined 
criteria (Fig. 1). Therefore, although HbA1c criteria alone iden-
tifies 42% [(11,316−6,531)/11,316] fewer subjects with IRD 
than does FPG criteria, about 20% [(13,556-11,316)/11,316] 
more could be detected as IRD by including new HbA1c crite-
ria in addition to FPG criteria. Among the 13,556 subjects with 
newly detected IRD, 7,025 (51.8%) met FPG criteria only (IRD-
FPG group), 2,240 (16.5%) met HbA1c criteria only (IRD-A1c 
group), and 4,291 (31.7%) met both criteria (Fig. 1). This trend 
was similar across all age groups, although the prevalences of 
Table 1.  Clinical characteristics of the health check-up recipi-
ents included in this study (n=34,133)
Characteristic Value
Age, yr 48.5±10.2
Sex, M/F, % 59.5/40.5
BMI, kg/m
2 23.8±2.9
Waist circumference, cm 83.0±8.7
SBP, mm Hg 115±13
DBP, mm Hg 72±10
Fasting glucose, mg/dL 98±15
HbA1c, % 5.3±0.6
Hb concentration, g/dL  
Men 15.4±1.0
Women 13.1±1.5
Fasting insulin, uU/mL 7.1±4.5
Triglyceride, mg/dL 130±84 
HDL-C, mg/dL 55±14 
Values are presented as mean±standard deviation.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; Hb, hemoglobin; HDL-C, high density lipoprotein 
cholesterol.153
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IRD were getting higher with increasing age (Fig. 2). Among 
subjects with pre-diabetes by FPG criterion (i.e., impaired fast-
ing glucose), 65% were normal, 32% were IRD, and 3% were 
diabetes by HbA1c criterion (Fig. 3). Sensitivity and specificity 
of different HbA1c cutoff points for FPG-based pre-diabetes 
(5.6 to 6.9 mmol/L) are shown in Table 2. The optimal cutoff 
point of HbA1c for IRD in reference to classical FPG-based 
pre-diabetes was 5.4%, with sensitivity and specificity of 63% 
and 65%, respectively (Fig. 4).
DISCUSSION
Our results confirmed that there was a significant discordance 
in diagnosing subjects with IRD between the FPG- and HbA1c-
based criteria. The prevalence of pre-diabetes was about 32% 
by FPG criteria, 18% by HbA1c criteria, and 38% by combin-
Table 2.  Sensitivity and specificity according to different 
HbA1c cutoff points for fasting plasma glucose-based pre-dia-
betes (impaired fasting glucose)
HbA1c, % Sensitivity, % Specificity, %
5.4 63 65
5.5 53 74
5.6 43 82
5.7 35 88
5.8 27 93
5.9 21 95
6.0 15 97
 7,025  
(19.7%)
51.8%  
among IRD
  4,291
(12.0%)
31.7%
among IRD
2,240
(6.3%)
16.5%
among IRD
11,316
(31.8%)
83.5% among IRD
IRD by combined criteria 13,556/35,624 total subject (38.1%)
FPG HbA1c
6,531
(18.1%)
48.2% among IRD
Fig. 1.  Discordance of newly detected increased risk for dia-
betes (IRD) as assessed during health check-ups according to 
fasting plasma glucose (FPG) and HbA1c criteria. FPG crite-
ria, FPG (5.6 to 6.9 mmol/L); HbA1c criteria, HbA1c (5.7% to 
6.4%); combined criteria, FPG (5.6 to 6.9 mmol/L) or HbA1c 
(5.7% to 6.4%).
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Fig. 2.  Prevalence of newly detected increased risk for diabe-
tes in different age groups by fasting plasma glucose (FPG) 
and HbA1c criteria. FPG criteria, FPG (5.6 to 6.9 mmol/L); 
HbA1c criteria, HbA1c (5.7% to 6.4%); combined criteria, 
FPG (5.6 to 6.9 mmol/L) or HbA1c (5.7% to 6.4%).
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Fig. 3.  Comparison of glycemic status categorized by fasting 
plasma glucose (FPG) and HbA1c criteria (FPG criteria: nor-
mal <5.6 mmol/L, pre-diabetes 5.6 to 6.9 mmol/L, diabetes 
≥7.0 mmol/L; HbA1c criteria: normal <5.7%, increased risk 
for diabetes 5.7% to 6.4%, diabetes ≥6.5%).
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ing both criteria. Only 12% met both criteria, and concordance 
rate between the two criteria was only about 31%. HbA1c cri-
terion has lower sensitivity in detecting subject with IRD com-
pared with FPG criteria, but introducing this new criterion 
could identify additional 20% of subjects with IRD. 
  Our results are consistent with previous reports in other 
populations that showed HbA1c criteria resulted in substan-
tially lower prevalences of being at high risk for diabetes, than 
prevalences estimated from FPG or oral glucose tolerance test. 
For example, analyses of the U.S. National Health and Nutri-
tion Examination Survey (NHANES 1999-2006) data indicate 
that the prevalence of pre-diabetes among U.S. adults was 28.2% 
by the fasting glucose criterion and 12.6% by the HbA1c crite-
rion [2]. Only 7.7% of U.S. adults had pre-diabetes according 
to both definitions. 
  As shown in this study, introducing additional HbA1c crite-
ria causes increased prevalence of IRD as well as diabetes. This 
may contribute to prevent or delay progression to diabetes and 
development of its complications by early lifestyle intervention. 
However, the stiff increase in prevalence of IRD may cause in-
adequate management due to shortage of health care resourc-
es. In addition, it can cause a large increase of initial health care 
cost (although not in long-term [7]), and unnecessary psycho-
logical stress for some subjects categorized as IRD. 
  In this study, additional detection rate of IRD by HbA1c in-
creased with age. This trend has also been observed in previ-
ous studies in other populations since HbA1c levels tend to 
increase with age [8]. Moreover, postchallenge glucose con-
centrations rise significantly with increasing age even in sub-
jects with normal glucose tolerance [9]. However, it is not 
practical to set different criteria according to age. Preparation 
of different guidelines according to age groups and combined 
other risk factors may be more practical. Prospective studies 
are needed to define the high risk group in which intensive 
screening and early intervention will be most beneficial. 
  The optimal cutoff point of HbA1c in reference to FPG-
based pre-diabetes was 5.4% in our study population, which is 
lower than the ADA-recommended cutoff value. In the Inter-
national Expert Committee [10] 2009 report, the group did 
not recommend classification of pre-diabetes, but noted that 
those with HbA1c levels 6.0% to <6.5% are at high risk of de-
veloping diabetes. However, the 6.0% to 6.5% range fails to 
identify a substantial number of patients who have IFG and/or 
IGT [1]. Prospective studies indicate that people within the 
HbA1c range of 5.5% to 6.0% have a 5-year cumulative inci-
dence of diabetes three- to eight-fold higher than incidence in 
the general population [11-13]. The ADA chose the HbA1c 
cut-point of 5.7% as it is less sensitive but more specific and 
has a higher positive predictive value to identify people at risk 
for later development of diabetes [1]. However, they noted that 
FPG of 100 mg/dL corresponds to an HbA1c of 5.4% by linear 
regression analysis among the non-diabetic adult population. 
The optimal cut-off point of HbA1c 5.4% for IFG obtained by 
ROC curve analysis of our data coincided well with that.
  There have been several reports that compared HbA1c-
based criteria with glucose-based criteria for diabetes in Kore-
ans [14-18]. However, little data are available about the validity 
and usefulness HbA1c criteria for detecting pre-diabetes in 
Koreans. An hospital-based study in high-risk group [16] 
showed that 76% of subjects with IFG or IGT had HbA1c 
≥5.7%, which is much higher than the 35% sensitivity for the 
same HbA1c cutoff value in our data. In another study exam-
ined 2,045 non-diabetic health check-up recipients, the cut-off 
value of baseline HbA1c predicting 4-year risk of developing 
diabetes was 5.35% [17], which is very close to our cut-off val-
ue (5.4%) for identifying pre-diabetes in ROC analysis.
  There are several limitations in our study. First, our study 
subjects were not a random sample of the general population. 
Therefore, we could not estimate the prevalence of IRD in Ko-
rean general population. The second limitation of our study is 
that no information for hemoglobinopathy was available in our 
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Fig. 4.  Receiver operating characteristic curves for HbA1c 
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ing plasma glucose-based pre-diabetes (impaired fasting glu-
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data. However, the prevalence of hemoglobinopathy is very low 
in Korea, and thus the hemoglobin abnormalities may have 
hardly influenced on the present results. In addition, we ex-
cluded all subjects with anemia regardless of its cause, since 
previous studies suggest that iron deficiency anemia also af-
fects the HbA1c levels [19,20]. 
  In conclusion, although HbA1c criteria alone identifies few-
er subjects with pre-diabetes than does FPG criteria, about 20% 
more could be detected as IRD by inclusion of HbA1c criteria 
in addition to FPG criteria. Addition of new HbA1c criteria 
may be useful in detecting the subjects with IRD, but may also 
cause increase of initial cost for health care and psycho-social 
burden. Further studies are needed to establish optimal HbA1c 
cutoff point, and guidelines for screening and management in 
general population. 
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